Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer
Business Wire•17/08/2026•07:30 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.